ANGPTL4 and coronary artery disorder: For instance, in one study by Muendlein et al., its increased concentration exacerbated the risk of coronary artery disease (CAD) [19], and in the other, by Sun et al., decreased ANGPTL4 was significantly related to CAD, regardless of lipid concentrations, and presented as a CAD biomarker [20].